Bracebridge Corporate Finance has advised on the sale of Industrial, Medical & Safety Services Limited (“IMASS”) to leading Occupational Health and Wellbeing providers, Medigold Health Consultancy Ltd (“Medigold Health”).

Founded over 20 years ago by Dr Paul Yarnley, IMASS are established experts in the field of Occupational Health with a particular and impressive focus on the South West of the UK and in providing services to the UK public sector. They have shown year on year growth and are on track to achieve £5m turnover this year. Their services include health screening, medical assessments and absence management.

Steve Way, Managing Director, who joined the company in 1998, will be continuing in his current role and also supporting Medigold Health with its future growth strategy. 

Steve commented: “Myself and the senior team at IMASS are truly excited to be joining the Medigold Health Group and we are delighted to have found the right home for IMASS as it looks to take the next step in its development. We are extremely proud of the entire team and we have every confidence that the company will continue to expand and provide high quality services under Medigold Health’s ownership. We are looking forward to working with all within the Medigold Health Group as it continues its journey to becoming the number one occupational health provider in the UK in both size and quality.”

Medigold Health is one of the UK’s most respected and established independent providers of corporate healthcare services. Still family owned, Medigold Health has been dedicated to the business of helping employers keep their people in work, safe and well, for almost two decades and, in doing so, redefining corporate healthcare in the UK.

CEO of Medigold Health, Alex Goldsmith, commented; “The Medigold Health brand has been built on uncompromising principles of quality, integrity and continuous improvement. We are extremely proud of our track record in these areas and we firmly believe that IMASS espouse the same strengths and values. It is our hope and intention for this exciting acquisition to significantly enhance the Medigold Health brand across the UK.”

Bracebridge Corporate Finance was appointed to explore the strategic options for sale and to advise on the sale process. Andy Moore, Managing Director of Bracebridge Corporate Finance added: “This is an excellent result for the shareholders of IMASS. The acquisition is part of Medigold Health’s continued expansion of its service offering and geographic presence”.

Steve added ”We have enjoyed working with Bracebridge. Andy has worked closely with us, providing strategic support and excellent advice throughout the transaction process”.